Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
World Journal of Urology
|
September 23, 2025
The role of phosphatidylinositol (18:1_18:1) in benign prostatic hyperplasia: an integrated study of Mendelian randomization and network pharmacology
Bingliang Chen, Zhen He, Shirong Peng, et al.
ACS Biomaterials Science & Engineering
|
June 8, 2024
Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy
Shunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
Annals of Surgical Oncology
|
September 17, 2024
Comparison in Efficacy of Periurethral Reconstruction Leading to Urinary Continence Improvement After Robot-assisted Radical Prostatectomy
Xutu Zhao, Kaiwen Li, Ruilin Zhuang, et al.
Cancer Pathogenesis and Therapy
|
October 7, 2024
Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study
Peixian Chen, Yue Wang, Zhi Xiong, et al.
Advanced Healthcare Materials
|
May 27, 2025
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug Carrier
Bingliang Chen, Liying Wang, Ruihui Xie, et al.
International Journal of Surgery (London, England)
|
June 27, 2025
Regulation of macrophage plasticity by circCCDC719-13 through HSP90 inhibition suppresses prostate cancer progression and metastasis: a translational study
Bisheng Cheng, Jianghua Yang, Wenxue Huang, et al.
Biomaterials Science
|
January 3, 2024
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression
Zhi Xiong, Tong Tong, Zhaoxiang Xie, et al.
Journal of Translational Medicine
|
April 27, 2025
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer
Ruilin Zhuang, Ruihui Xie, Shirong Peng, et al.
Cell Death & Disease
|
February 23, 2026
PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer
Ruilin Zhuang, Qianghua Zhou, Bisheng Cheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 28, 2026
Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
Shirong Peng, Weilong Lin, Zean Li, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
World Journal of Urology
|
September 23, 2025
The role of phosphatidylinositol (18:1_18:1) in benign prostatic hyperplasia: an integrated study of Mendelian randomization and network pharmacology
Bingliang Chen, Zhen He, Shirong Peng, et al.
ACS Biomaterials Science & Engineering
|
June 8, 2024
Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy
Shunli Yu, Ruhe Zhang, Zhaoxiang Xie, et al.
Annals of Surgical Oncology
|
September 17, 2024
Comparison in Efficacy of Periurethral Reconstruction Leading to Urinary Continence Improvement After Robot-assisted Radical Prostatectomy
Xutu Zhao, Kaiwen Li, Ruilin Zhuang, et al.
Cancer Pathogenesis and Therapy
|
October 7, 2024
Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study
Peixian Chen, Yue Wang, Zhi Xiong, et al.
Advanced Healthcare Materials
|
May 27, 2025
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug Carrier
Bingliang Chen, Liying Wang, Ruihui Xie, et al.
International Journal of Surgery (London, England)
|
June 27, 2025
Regulation of macrophage plasticity by circCCDC719-13 through HSP90 inhibition suppresses prostate cancer progression and metastasis: a translational study
Bisheng Cheng, Jianghua Yang, Wenxue Huang, et al.
Biomaterials Science
|
January 3, 2024
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression
Zhi Xiong, Tong Tong, Zhaoxiang Xie, et al.
Journal of Translational Medicine
|
April 27, 2025
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer
Ruilin Zhuang, Ruihui Xie, Shirong Peng, et al.
Cell Death & Disease
|
February 23, 2026
PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer
Ruilin Zhuang, Qianghua Zhou, Bisheng Cheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 28, 2026
Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
Shirong Peng, Weilong Lin, Zean Li, et al.
Page
of 1